Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC9A1 | P19634 | 1/20 | 0.37 |
| ▸ | KHK | P50053 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | NQO1 | P15559 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | GLP1R | P43220 | 1/20 | 0.31 |
| ▸ | NPC1 | O15118 | 1/20 | 0.30 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26961128 | 0.85 | SLC9A1 (0.39) | SLC9A1KHKGAANQO1 | |
| SCHEMBL8114322 | 0.83 | CYP3A4 (0.37) | CYP3A4 | |
| SCHEMBL7857498 | 0.82 | KHK (0.48) | SLC9A1KHKGAANQO1CYP3A4 | |
| SCHEMBL29964210 | 0.81 | HTT (0.35) | SLC9A1KHK | |
| SCHEMBL23148089 | 0.78 | HTT (0.37) | KHKGAA | |
| SCHEMBL7786072 | 0.78 | MPL (0.35) | SLC9A1GAA | |
| SCHEMBL10817777 | 0.76 | TDP1 (0.35) | CYP3A4ALDH1A1 | |
| SCHEMBL21246976 | 0.76 | SLC9A1 (0.38) | SLC9A1KHKGAANQO1CYP3A4 | |
| SCHEMBL10475171 | 0.72 | HSD17B10 (0.36) | CYP3A4ALDH1A1 | |
| SCHEMBL11420258 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025226670-A1 | INHIBITORS OF FATTY ACID BINDING PROTEINS (FABPS), METHODS OF USE AND METHODS OF MAKING | CELLORAM, INC. (US) | 2025-10-30 | — | — | WO | disclosed |
| US-20250325529-A1 | INHIBITORS OF FATTY ACID BINDING PROTEINS (FABPs), METHODS OF USE AND METHODS OF MAKING | CELLORAM, INC. (US) | 2025-10-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250325529-A1 | INHIBITORS OF FATTY ACID BINDING PROTEINS (FABPs), METHODS OF USE AND METHODS OF MAKING | FABP1, FABP4, FABP7 | SLC9A1 4442/4885KHK 1617/4885GAA 1047/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.